HIV-Resistant and HIV-Specific CAR-Modified CD4+ T Cells Mitigate HIV Disease Progression and Confer CD4+ T Cell Help In Vivo
2020 · Molecular Therapy · 45 citations
https://doi.org/10.1016/j.ymthe.2020.05.012
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
177
Citations
3
h-index
2
i10-index
Derrick L. Dopkin is an academic researcher from California University of Pennsylvania. The author has contributed to research in topics: HIV Research and Treatment & Immune Cell Function and Interaction & CAR-T cell therapy research. The author has an h-index of 3, co-authored 4 publications.
Click to start Chat